Poxel secures Japanese patent for diabetes-targeting molecule

French biotech Poxel has secured a Japanese patent covering its candidate molecule against diabetes and metabolic diseases.

Published 8sem1 sourceNotableupdated 8sem

≈ 23sSpeed

The fact

This intellectual property protection strengthens the company's position in the Asian market, a key segment for the pharmaceutical sector.

The patent expands Poxel's intellectual property portfolio and supports the valuation of its therapeutic pipeline.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 20, 2026